Embecta Corp

NASDAQ EMBC

Download Data

Embecta Corp Operating Cash Flow Per Share for the quarter ending March 31, 2024: 0.42

Embecta Corp Operating Cash Flow Per Share is 0.42 for the quarter ending March 31, 2024, a 285.97% change year over year. Operating cash flow per share represents the amount of cash generated from a company's core operations per outstanding share. It is calculated by dividing the operating cash flow by the weighted average number of basic shares outstanding. This metric provides insights into the company's ability to generate cash flow from its day-to-day operations on a per-share basis. It is useful for evaluating the company's cash flow generation and comparing it with other companies on a per-share basis.
  • Embecta Corp Operating Cash Flow Per Share for the quarter ending March 31, 2023 was -0.23, a -107.15% change year over year.
  • Embecta Corp Operating Cash Flow Per Share for the quarter ending March 31, 2022 was 3.16, a 50.44% change year over year.
  • Embecta Corp Operating Cash Flow Per Share for the quarter ending March 31, 2021 was 2.10.
NASDAQ: EMBC

Embecta Corp

CEO Mr. Devdatt Kurdikar
IPO Date April 1, 2022
Location United States
Headquarters 300 Kimball Drive, Parsippany, NJ, United States, 07054
Employees 2,200
Sector Healthcare
Industry Medical instruments & supplies
Description

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient's diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Similar companies

ANGO

AngioDynamics Inc

NA

NA

AKYA

Akoya Biosciences Inc

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email